As of Feb 20, 2025, Encompass Health Corporation Intrinsic Value is $84.2. This suggests it may be overvalued by 15.7% compared to its current price of around $99.9.
As of Feb 20, 2025, Encompass Health Corporation's Discounted Cash Flow (DCF) valuation estimates its share price at N/A. This suggests it may be overvalued by N/A to its current price of around $99.9, using a discount rate of 8.1% and terminal growth rate of 3.0%.
Encompass Health Corporation is currently considered overvalued based on its Discounted Cash Flow (DCF) valuation and Relative Valuation, which estimates its share price to be $84.2, compared to a market price of around $99.9. This suggests a potential overvaluation of 15.7%.